A high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology ...

Reductions seen in office systolic blood pressure for those in no-CKD, stage 3a CKD, and stage 3b CKD groups. (HealthDay News) — Radiofrequency renal denervation (RDN) yields a clinically meaningful ...

Dependence in ADL 2.16 (1.42–3.30) 1.60 (1.20–2.14) 1.04 (0.86–1.25) <0.001 Lack of physical activity 2.20 (1.39–3.48) 1.78 (1.37–2.32) 1.10 (0.92–1.32) <0.001 Falls 2.04 (1.26–3.31) 1.06 (0.78–1.43) ...

In April 2021, dapagliflozin (Farxiga) received a new indication from the US Food and Drug Administration (FDA) for slowing progression of chronic kidney disease (CKD) in people without any other ...